Jaime Espín

Learn More
1 Disclaimer This document has been prepared in the framework of a service contract with the European Commission (Directorate-General for Enterprise and Industry). The views expressed therein are purely those of the writers and should not be regarded as stating a position of the European Commission or its services. The European Commission does not guarantee(More)
BACKGROUND With the emergence of influenza H1N1v the world is facing its first 21st century global pandemic. Severe Acute Respiratory Syndrome (SARS) and avian influenza H5N1 prompted development of pandemic preparedness plans. National systems of public health law are essential for public health stewardship and for the implementation of public health(More)
BACKGROUND Mental health disorders (MHDs) constitute a large and growing disease burden in Europe, although they typically receive less attention and research funding than other non-communicable diseases (NCDs). This study protocol describes a methodology for the mapping of MHD research in Europe as part of Mapping_NCD, a 2-year project funded by the(More)
Background Policy-makers aim to achieve the partially conflicting objectives of equitable access to medicines, cost containment and sustainable funding as well as reward for innovation. To do so, a range of policy options is available that has been extended in recent years to meet new challenges. Objectives To identify existing pharmaceutical reimbursement(More)
  • 1